Last-Recorded P2Y12 Reaction Units Value Is Strongly Associated with Thromboembolic and Hemorrhagic Complications Occurring Up to 6 Months after Treatment in Patients with Cerebral Aneurysms Treated with the Pipeline Embolization Device

REFERENCES

1. 1.↵
   1. Lylyk P,
   2. Miranda C,
   3. Ceratto R,
   4. et al

   . Curative endovascular reconstruction of cerebral aneurysms with the Pipeline embolization device: the Buenos Aires experience. Neurosurgery 2009;64:632–42

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Szikora I,
   2. Berentei Z,
   3. Kulcsar Z,
   4. et al

   . Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the Pipeline embolization device. AJNR Am J Neuroradiol 2010;31:1139–47

   Abstract/FREE Full Text
3. 3.↵
   1. Nelson PK,
   2. Lylyk P,
   3. Szikora I,
   4. et al

   . The Pipeline embolization device for the intracranial treatment of aneurysms trial. AJNR Am J Neuroradiol 2011;32:34–40

   Abstract/FREE Full Text
4. 4.↵
   1. Lubicz B,
   2. Collignon L,
   3. Raphaeli G,
   4. et al

   . Pipeline flow-diverter stent for endovascular treatment of intracranial aneurysms: preliminary experience in 20 patients with 27 aneurysms. World Neurosurg 2011;76:114–19

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Fischer S,
   2. Vajda Z,
   3. Aguilar Perez M,
   4. et al

   . Pipeline embolization device (PED) for neurovascular reconstruction: initial experience in the treatment of 101 intracranial aneurysms and dissections. Neuroradiology 2012;54:369–82

   CrossRefPubMedWeb of Science
6. 6.↵
   1. McAuliffe W,
   2. Wycoco V,
   3. Rice H,
   4. et al

   . Immediate and midterm results following treatment of unruptured intracranial aneurysms with the Pipeline embolization device. AJNR Am J Neuroradiol 2012;33:164–70

   Abstract/FREE Full Text
7. 7.↵
   1. Deutschmann HA,
   2. Wehrschuetz M,
   3. Augustin M,
   4. et al

   . Long-term follow-up after treatment of intracranial aneurysms with the Pipeline embolization device: results from a single center. AJNR Am J Neuroradiol 2012;33:481–86

   Abstract/FREE Full Text
8. 8.↵
   1. Cruz JP,
   2. Chow M,
   3. O'Kelly C,
   4. et al

   . Delayed ipsilateral parenchymal hemorrhage following flow diversion for the treatment of anterior circulation aneurysms. AJNR Am J Neuroradiol 2012;33:603–08

   Abstract/FREE Full Text
9. 9.↵
   1. Colby GP,
   2. Lin LM,
   3. Gomez JF,
   4. et al

   . Immediate procedural outcomes in 35 consecutive Pipeline embolization cases: a single-center, single-user experience. J Neurointerv Surg 2013;5:237–46

   Abstract/FREE Full Text
10. 10.↵
    1. Chitale R,
    2. Gonzalez LF,
    3. Randazzo C,
    4. et al

    . Single center experience with Pipeline stent: feasibility, technique and complications. Neurosurgery 2012;71:679–91

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Phillips TJ,
    2. Wenderoth JD,
    3. Phatouros CC,
    4. et al

    . Safety of the Pipeline embolization device in treatment of posterior circulation aneurysms. AJNR Am J Neuroradiol 2012;33:1225–31

    Abstract/FREE Full Text
12. 12.↵
    1. Saatci I,
    2. Yavuz K,
    3. Ozer C,
    4. et al

    . Treatment of intracranial aneurysms using the Pipeline flow-diverter embolization device: a single-center experience with long-term follow-up results. AJNR Am J Neuroradiol 2012;33:1436–46

    Abstract/FREE Full Text
13. 13.↵
    1. O'Kelly CJ,
    2. Spears J,
    3. Chow M,
    4. et al

    . Canadian experience with the Pipeline embolization device for repair of unruptured intracranial aneurysms. AJNR Am J Neuroradiol 2013;34:381–87

    Abstract/FREE Full Text
14. 14.↵
    1. Kan P,
    2. Siddiqui AH,
    3. Veznedaroglu E,
    4. et al

    . Early postmarket results after treatment of intracranial aneurysms with the Pipeline embolization device: a U.S. multicenter experience. Neurosurgery 2012;71:1080–87

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Yu SC,
    2. Kwok CK,
    3. Cheng PW,
    4. et al

    . Intracranial aneurysms: midterm outcome of Pipeline embolization device: a prospective study in 143 patients with 178 aneurysms. Radiology 2012;265:893–901

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Delgado Almandoz JE,
    2. Crandall BM,
    3. Scholz JM,
    4. et al

    . Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device. J Neurointerv Surg 2013; 5 Suppl 3:iii3–10

    Abstract/FREE Full Text
17. 17.↵
    1. von Beckerath N,
    2. Pogatsa-Murray G,
    3. Wieczorek A,
    4. et al

    . Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness. Thromb Haemost 2006;95:910–11

    PubMedWeb of Science
18. 18.↵
    1. Jakubowski JA,
    2. Payne CD,
    3. Li YG,
    4. et al

    . The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration. Thromb Haemost 2008;99:409–15

    PubMedWeb of Science
19. 19.↵
    1. Varenhorst C,
    2. James S,
    3. Erlinge D,
    4. et al

    . Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin. Am Heart J 2009;157:562.e1–9

    CrossRefPubMed
20. 20.↵
    1. Jeong YH,
    2. Bliden KP,
    3. Antonino MJ,
    4. et al

    . Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies. Am Heart J 2012;164:35–42

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Bonello L,
    2. Tantry US,
    3. Marcucci R,
    4. et al

    . Working group on high on-treatment platelet reactivity: consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 2010;56:919–33

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Akbari SH,
    2. Reynolds MR,
    3. Kadkhodayan Y,
    4. et al

    . Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. J Neurointerv Surg 2013;5:337–43

    Abstract/FREE Full Text
23. 23.↵
    1. Lee DH,
    2. Arat A,
    3. Morsi H,
    4. et al

    . Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience. AJNR Am J Neuroradiol 2008;29:1389–94

    Abstract/FREE Full Text
24. 24.↵
    1. Goh C,
    2. Churilov L,
    3. Mitchell P,
    4. et al

    . Clopidogrel hyper-response and bleeding risk in neurointerventional procedures. AJNR Am J Neuroradiol 2013;34:721–26

    Abstract/FREE Full Text
25. 25.↵
    1. Altay T,
    2. Kang HI,
    3. Woo HH,
    4. et al

    . Thromboembolic events associated with endovascular treatment of cerebral aneurysms. J Neurointerv Surg 2011;3:147–50

    Abstract/FREE Full Text
26. 26.↵
    1. Deshmukh V,
    2. Hu YC,
    3. McDougall CG,
    4. et al

    . Histopathological assessment of delayed ipsilateral parenchymal hemorrhages after the treatment of paraclinoid aneurysms with the Pipeline embolization device [abstract]. Neurosurgery 2012;71:E551–52